Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1974 Jun;29(6):425–432. doi: 10.1038/bjc.1974.94

A Common Tumour Specific Antigen

II. Further Characterization of the Whole Antigen and of a Cross-Reacting Antigen of Normal Tissues

J P Dickinson, J R McDermott, J K Smith, E A Caspary
PMCID: PMC2009113  PMID: 4527605

Abstract

Experimental evidence supporting the postulated analogy between myelin basic protein and a previously described common tumour specific antigen is summarized under antigenic cross-reactivity, subcellular localization, molecular size, basicity and proteolipid nature. A third protein antigen, present in all tissues, also shows strong similarities in all these respects.

Full text

PDF
425

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams D. H., Fox M. E. The homogeneity and protein composition of rat brain myelin. Brain Res. 1969 Aug;14(3):647–661. doi: 10.1016/0006-8993(69)90205-4. [DOI] [PubMed] [Google Scholar]
  2. Agrawal H. C., Burton R. M., Fishman M. A., Mitchell R. F., Prensky A. L. Partial characterization of a new myelin protein component. J Neurochem. 1972 Sep;19(9):2083–2089. doi: 10.1111/j.1471-4159.1972.tb05118.x. [DOI] [PubMed] [Google Scholar]
  3. Bach F. H., Widmer M. B., Bach M. L., Klein J. Serologically defined and lymphocyte-defined components of the major histocompatibility complex in the mouse. J Exp Med. 1972 Dec 1;136(6):1430–1444. doi: 10.1084/jem.136.6.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bergstrand H. Localization of antigenic deterinants on bovine encephalitogenic protein. Studies with a second set of protein fragments and the macrophage-migration-inhibition technique in guinea pigs. Eur J Biochem. 1972 May;27(1):126–135. doi: 10.1111/j.1432-1033.1972.tb01818.x. [DOI] [PubMed] [Google Scholar]
  5. CASPARY E. A., FIELD E. J. AN ENCEPHALITOGENIC PROTEIN OF HUMAN ORIGIN: SOME CHEMICAL AND BIOLOGICAL PROPERTIES. Ann N Y Acad Sci. 1965 Mar 31;122:182–198. doi: 10.1111/j.1749-6632.1965.tb20202.x. [DOI] [PubMed] [Google Scholar]
  6. Carnegie P. R., Caspary E. A., Dickinson J. P., Field E. J. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics. Clin Exp Immunol. 1973 May;14(1):37–45. [PMC free article] [PubMed] [Google Scholar]
  7. Carnegie P. R., Caspary E. A., Field E. J. Identification of a tumour antigen. Biochem J. 1972 Feb;126(3):5P–6P. doi: 10.1042/bj1260005p. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Caspary E. A., Field E. J. Specific lymphocyte sensitization in cancer: is there a common antigen in human malignant neoplasia? Br Med J. 1971 Jun 12;2(5762):613–617. doi: 10.1136/bmj.2.5762.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dickinson J. P., Caspary E. A., Field E. J. A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer. 1973 Feb;27(2):99–105. doi: 10.1038/bjc.1973.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dickinson J. P., Caspary E. A., Field E. J. Localization of tumour specific antigen on external surface of plasma membrane. Nat New Biol. 1972 Oct 11;239(93):181–183. doi: 10.1038/newbio239181a0. [DOI] [PubMed] [Google Scholar]
  11. Dickinson J. P., Jones K. M., Aparicio S. R., Lumsden C. E. Localization of encephalitogenic basic protein in the intraperiod line of lamellar myelin. Nature. 1970 Sep 12;227(5263):1133–1134. doi: 10.1038/2271133a0. [DOI] [PubMed] [Google Scholar]
  12. Eylar E. H., Salk J., Beveridge G. C., Brown L. V. Experimental allergic encephalomyelitis. An encephalitogenic basic protein from bovine myelin. Arch Biochem Biophys. 1969 Jun;132(1):34–48. doi: 10.1016/0003-9861(69)90336-1. [DOI] [PubMed] [Google Scholar]
  13. Field E. J., Caspary E. A. Lymphocyte sensitisation: an in-vitro test for cancer? Lancet. 1970 Dec 26;2(7687):1337–1341. doi: 10.1016/s0140-6736(70)92361-5. [DOI] [PubMed] [Google Scholar]
  14. Field E. J., Hughes D., Caspary E. A. Rapid development of a cancer-like antigen in normal tissue in vitro. Br J Cancer. 1973 Jun;27(6):427–433. doi: 10.1038/bjc.1973.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Gonzalez-Sastre F. The protein composition of isolated myelin. J Neurochem. 1970 Jul;17(7):1049–1056. doi: 10.1111/j.1471-4159.1970.tb02258.x. [DOI] [PubMed] [Google Scholar]
  16. Gutterman J. U., Mavligit G., McCredie K. B., Bodey G. P., Sr, Freireich E. J., Hersh E. M. Antigen solubilized from human leukemia: lymphocyte stimulation. Science. 1972 Sep 22;177(4054):1114–1115. doi: 10.1126/science.177.4054.1114. [DOI] [PubMed] [Google Scholar]
  17. Hughes D., Paty D. W. Lymphocyte sensitivity in cancer. Br Med J. 1971 Jun 26;2(5764):770–770. doi: 10.1136/bmj.2.5764.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LEES M. B. THE SOLUBILITY PROPERTIES OF PROTEOLIPIDS. Ann N Y Acad Sci. 1965 Mar 31;122:116–128. doi: 10.1111/j.1749-6632.1965.tb20197.x. [DOI] [PubMed] [Google Scholar]
  19. Lumsden C. E., Robertson D. M., Blight R. Chemical studies on experimental allergic encephalomyelitis. Peptide as the common denominator in all encephalitogenic 'antigens'. J Neurochem. 1966 Mar;13(3):127–162. doi: 10.1111/j.1471-4159.1966.tb07507.x. [DOI] [PubMed] [Google Scholar]
  20. McFarland W., Heilman D. H. Comparison of lymphocyte transformation and intradermal reactions to tuberculins. Am Rev Respir Dis. 1966 May;93(5):742–748. doi: 10.1164/arrd.1966.93.5.742. [DOI] [PubMed] [Google Scholar]
  21. Meltzer M. S., Leonard E. J., Rapp H. J., Borsos T. Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst. 1971 Sep;47(3):703–709. [PubMed] [Google Scholar]
  23. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Evaluation and development of the macrophage electrophoretic mobility (MEM) test for malignant disease. Br J Cancer. 1973 Jan;27(1):1–9. doi: 10.1038/bjc.1973.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pritchard J. A., Moore J. L., Sutherland W. H., Joslin C. A. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation. Lancet. 1972 Sep 23;2(7778):627–629. doi: 10.1016/s0140-6736(72)93018-8. [DOI] [PubMed] [Google Scholar]
  25. Spitler L. E., Von Muller C. M., Fudenberg H. H., Eylar E. H. Experimental allergic encephalitis. Dissociation of cellular immunity to brain protein and disease production. J Exp Med. 1972 Jul 1;136(1):156–174. doi: 10.1084/jem.136.1.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Swanborg R. H. Immunologic response to altered encephalitogenic protein in guinea pigs. J Immunol. 1969 Feb;102(2):381–388. [PubMed] [Google Scholar]
  27. Uyemura K., Tobari C., Hirano S. Purifications and properties of basic proteins in pig spinal cord and peripheral nerve. Biochim Biophys Acta. 1970 Jul 27;214(1):190–197. doi: 10.1016/0005-2795(70)90083-8. [DOI] [PubMed] [Google Scholar]
  28. Wolfgram F. A new proteolipid fraction of the nervous system. I. Isolation and amino acid analyses. J Neurochem. 1966 Jun;13(6):461–470. doi: 10.1111/j.1471-4159.1966.tb09859.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES